Revolutionizing Cancer Care: New NCCN Guidelines Embrace ctDNA-MRD Testing
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Foresight Diagnostics, a pioneer in ultra-sensitive minimal residual disease (MRD) detection technology,…
Revolutionizing Cancer Care: New NCCN Guidelines Embrace ctDNA-MRD Testing Read More